德國(guó)Biotest www.biotest.com  www.biotest.de
Biotest公司是全球領(lǐng)先的血液和生物制品研發(fā)和生產(chǎn)企業(yè)，成立于1946年，1987年在法蘭克福證券交易所上市，2007年入選德意志交易所SDAX指數(shù)。Biotest從血漿中最大限度分離純化高價(jià)值藥用成分的能力在全球同類企業(yè)中較為突出，其遵循嚴(yán)格的血漿采集、檢驗(yàn)和生產(chǎn)規(guī)范，產(chǎn)品質(zhì)量穩(wěn)定、可靠。Biotest公司與復(fù)星醫(yī)藥的合作將有助于緩解中國(guó)市場(chǎng)人血白蛋白供應(yīng)的緊張狀況，創(chuàng)造良好的社會(huì)效益。

德國(guó)Biotest 
Biotest is a company specialising in innovative haematology and immunology products with the holistic approach of a global pharmaceutical, diagnostics and biotherapeutics group. Its approximately 1,200 employees develop, manufacture and sell medicinal products for the treatment of blood and immune diseases as well as reagents and systems for diagnostic purposes in transfusion and transplantation medicine. Biotest is, in addition, one of the leading manufacturers of products for the hygiene monitoring of air and work surfaces.
The most important starting material for our pharmaceutical products is human blood plasma which we process into effective and highly pure medicinal products in one of the world’s most modern production facilities in Europe. Our products are used in the treatment of life-threatening diseases such as coagulation disorders (haemophilia), severe infections or disorders of the immune system. One of our highest priority research projects is the development of monoclonal antibodies, active substances produced by biotechnological techniques, which will open up new prospects in the treatment of rheumatism, leukaemia and other autoimmune diseases.
Biotest products meet the highest standards and are sold in markets which have to satisfy the most stringent registration requirements in the world. Patients, hospitals, medical practices, laboratories and companies in 159 countries around the globe put their trust in Biotest’s quality and safety.